2018
DOI: 10.1080/15548627.2018.1476812
|View full text |Cite
|
Sign up to set email alerts
|

AT 101 induces early mitochondrial dysfunction and HMOX1 (heme oxygenase 1) to trigger mitophagic cell death in glioma cells

Abstract: ACD, autophagic cell death; ACN, acetonitrile; AT 101, (-)-gossypol; BAF, bafilomycin A; BAK1, BCL2-antagonist/killer 1; BAX, BCL2-associated X protein; BH3, BCL2 homology region 3; BNIP3, BCL2 interacting protein 3; BNIP3L, BCL2 interacting protein 3 like; BP, Biological Process; CCCP, carbonyl cyanide m-chlorophenyl hydrazone; CC, Cellular Component; Con, control; CQ, chloroquine; CRISPR, clustered regularly interspaced short palindromic repeats; DMEM, Dulbecco's Modified Eagle Medium; DTT, 1,4-dithiothreito… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
80
1
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 90 publications
(85 citation statements)
references
References 79 publications
3
80
1
1
Order By: Relevance
“…Silencing of heme oxygenase 1 (HMOX1) and the mitophagy receptors BCL2-interacting protein 3 (BNIP3) and BNIP3-like (BNIP3L), significantly attenuated AT-101-dependent mitophagy and cell death. Collectively, these data suggest that early mitochondrial dysfunction and HMOX1 over activation synergize to trigger lethal mitophagy following AT-101 treatment of GBM cells (Figure 3) [81,82].…”
Section: Pro-death Mitophagy Triggered By Gossypol/at-101mentioning
confidence: 80%
See 1 more Smart Citation
“…Silencing of heme oxygenase 1 (HMOX1) and the mitophagy receptors BCL2-interacting protein 3 (BNIP3) and BNIP3-like (BNIP3L), significantly attenuated AT-101-dependent mitophagy and cell death. Collectively, these data suggest that early mitochondrial dysfunction and HMOX1 over activation synergize to trigger lethal mitophagy following AT-101 treatment of GBM cells (Figure 3) [81,82].…”
Section: Pro-death Mitophagy Triggered By Gossypol/at-101mentioning
confidence: 80%
“…In particular, we found that AT-101 impaired mitochondrial respiration and rapidly triggered mitochondrial membrane depolarization. We also observed the engulfment of mitochondria within autophagosomes using electron microscopy (EM), and a significant reduction of mitochondrial mass and proteins, as determined with the mito-Keima assay and by global proteomic analysis of U87 and U343 GBM cells, that neither depend on the presence of Parkin nor the proapoptotic BCL-2 family proteins BAX and BAK1 [73,81,82].…”
Section: Pro-death Mitophagy Triggered By Gossypol/at-101mentioning
confidence: 90%
“…Heme is also the main target of HMOX‐1 (Gozzelino et al , ), an antioxidant factor which was highly up‐regulated in response to HIV‐1 replication in our experiments. Intriguingly, the PML‐depleting drug ATO is known to induce upregulation of HMOX‐1 (Meyer et al , ), further suggesting the possibility that HMOX‐1 expression might respond to lowered PML levels.…”
Section: Discussionmentioning
confidence: 99%
“…Cytoprotective roles of autophagy have for example been illustrated in several models of neurodegenerative diseases (ND), such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS) and Huntington's disease (HD), where the selective removal of pathological protein aggregates or damaged organelles via selective autophagy can support cell survival 10,22-24 .Since the induction of autophagy offers novel options to modulate human diseases 25 , the identification and characterization of compounds that stimulate autophagy has attracted special interest. In recent years, several natural compounds, small molecules and Food & Drug Administration (FDA)-approved drugs have been reported to induce autophagy and ACD under different cellular conditions and in different cell types [26][27][28][29][30] . Furthermore, triggering compound-induced autophagy and ACD has attracted particular interest, since many cancer types acquire loss-of-function mutations in conventional cell death pathways, like apoptosis, rendering them resistant against conventional chemotherapies 31 .Recently, we demonstrated that STF-62247 and pimozide trigger autophagy in glioblastoma (GBM) cells leading to ACD 30 .…”
mentioning
confidence: 99%
“…Since the induction of autophagy offers novel options to modulate human diseases 25 , the identification and characterization of compounds that stimulate autophagy has attracted special interest. In recent years, several natural compounds, small molecules and Food & Drug Administration (FDA)-approved drugs have been reported to induce autophagy and ACD under different cellular conditions and in different cell types [26][27][28][29][30] . Furthermore, triggering compound-induced autophagy and ACD has attracted particular interest, since many cancer types acquire loss-of-function mutations in conventional cell death pathways, like apoptosis, rendering them resistant against conventional chemotherapies 31 .…”
mentioning
confidence: 99%